ACV AUCTIONS INC-A (ACVA) Stock Fundamental Analysis

NYSE:ACVA • US00091G1040

6.66 USD
-0.09 (-1.33%)
At close: Feb 20, 2026
6.66 USD
0 (0%)
After Hours: 2/20/2026, 8:15:51 PM
Fundamental Rating

3

ACVA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 80 industry peers in the Commercial Services & Supplies industry. Both the profitability and financial health of ACVA have multiple concerns. ACVA is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • ACVA had negative earnings in the past year.
  • In the past year ACVA had a positive cash flow from operations.
  • In the past 5 years ACVA always reported negative net income.
  • In multiple years ACVA reported negative operating cash flow during the last 5 years.
ACVA Yearly Net Income VS EBIT VS OCF VS FCFACVA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

  • The Return On Assets of ACVA (-6.23%) is worse than 65.00% of its industry peers.
  • ACVA has a worse Return On Equity (-16.74%) than 62.50% of its industry peers.
Industry RankSector Rank
ROA -6.23%
ROE -16.74%
ROIC N/A
ROA(3y)-9.14%
ROA(5y)-9.1%
ROE(3y)-18.55%
ROE(5y)-17.56%
ROIC(3y)N/A
ROIC(5y)N/A
ACVA Yearly ROA, ROE, ROICACVA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -10 -20 -30

1.3 Margins

  • The Gross Margin of ACVA (53.30%) is better than 93.75% of its industry peers.
  • ACVA's Gross Margin has improved in the last couple of years.
  • ACVA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 53.3%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.78%
GM growth 5Y18.27%
ACVA Yearly Profit, Operating, Gross MarginsACVA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

3

2. Health

2.1 Basic Checks

  • ACVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ACVA has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for ACVA has been increased compared to 5 years ago.
  • Compared to 1 year ago, ACVA has a worse debt to assets ratio.
ACVA Yearly Shares OutstandingACVA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
ACVA Yearly Total Debt VS Total AssetsACVA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • ACVA has an Altman-Z score of 1.08. This is a bad value and indicates that ACVA is not financially healthy and even has some risk of bankruptcy.
  • ACVA's Altman-Z score of 1.08 is on the low side compared to the rest of the industry. ACVA is outperformed by 67.50% of its industry peers.
  • ACVA has a debt to FCF ratio of 4.81. This is a neutral value as ACVA would need 4.81 years to pay back of all of its debts.
  • ACVA has a better Debt to FCF ratio (4.81) than 73.75% of its industry peers.
  • A Debt/Equity ratio of 0.51 indicates that ACVA is somewhat dependend on debt financing.
  • ACVA's Debt to Equity ratio of 0.51 is in line compared to the rest of the industry. ACVA outperforms 50.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF 4.81
Altman-Z 1.08
ROIC/WACCN/A
WACC8.09%
ACVA Yearly LT Debt VS Equity VS FCFACVA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

  • ACVA has a Current Ratio of 1.62. This is a normal value and indicates that ACVA is financially healthy and should not expect problems in meeting its short term obligations.
  • ACVA's Current ratio of 1.62 is in line compared to the rest of the industry. ACVA outperforms 56.25% of its industry peers.
  • ACVA has a Quick Ratio of 1.62. This is a normal value and indicates that ACVA is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of ACVA (1.62) is better than 63.75% of its industry peers.
Industry RankSector Rank
Current Ratio 1.62
Quick Ratio 1.62
ACVA Yearly Current Assets VS Current LiabilitesACVA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

6

3. Growth

3.1 Past

  • ACVA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.43%, which is quite impressive.
  • ACVA shows a strong growth in Revenue. In the last year, the Revenue has grown by 23.40%.
  • The Revenue has been growing by 42.93% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)30.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70%
Revenue 1Y (TTM)23.4%
Revenue growth 3Y21.14%
Revenue growth 5Y42.93%
Sales Q2Q%16.48%

3.2 Future

  • ACVA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 37.83% yearly.
  • Based on estimates for the next years, ACVA will show a quite strong growth in Revenue. The Revenue will grow by 14.21% on average per year.
EPS Next Y16.89%
EPS Next 2Y25.41%
EPS Next 3Y25.49%
EPS Next 5Y37.83%
Revenue Next Year19.4%
Revenue Next 2Y15.74%
Revenue Next 3Y15.2%
Revenue Next 5Y14.21%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ACVA Yearly Revenue VS EstimatesACVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B
ACVA Yearly EPS VS EstimatesACVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 1 2

2

4. Valuation

4.1 Price/Earnings Ratio

  • ACVA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ACVA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ACVA Price Earnings VS Forward Price EarningsACVA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ACVA indicates a somewhat cheap valuation: ACVA is cheaper than 66.25% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 25.06
EV/EBITDA N/A
ACVA Per share dataACVA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ACVA's earnings are expected to grow with 25.49% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.41%
EPS Next 3Y25.49%

0

5. Dividend

5.1 Amount

  • No dividends for ACVA!.
Industry RankSector Rank
Dividend Yield 0%

ACV AUCTIONS INC-A

NYSE:ACVA (2/20/2026, 8:15:51 PM)

After market: 6.66 0 (0%)

6.66

-0.09 (-1.33%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)11-05
Earnings (Next)02-23
Inst Owners101.81%
Inst Owner Change-0.06%
Ins Owners2.47%
Ins Owner Change4.47%
Market Cap1.15B
Revenue(TTM)735.48M
Net Income(TTM)-72.72M
Analysts76
Price Target10.92 (63.96%)
Short Float %6.51%
Short Ratio4.21
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)41.07%
Min EPS beat(2)35.62%
Max EPS beat(2)46.52%
EPS beat(4)3
Avg EPS beat(4)24.22%
Min EPS beat(4)-9.21%
Max EPS beat(4)46.52%
EPS beat(8)6
Avg EPS beat(8)12.04%
EPS beat(12)10
Avg EPS beat(12)21.46%
EPS beat(16)13
Avg EPS beat(16)17.95%
Revenue beat(2)0
Avg Revenue beat(2)-2.65%
Min Revenue beat(2)-3.16%
Max Revenue beat(2)-2.13%
Revenue beat(4)0
Avg Revenue beat(4)-1.79%
Min Revenue beat(4)-3.16%
Max Revenue beat(4)-0.24%
Revenue beat(8)2
Avg Revenue beat(8)-0.54%
Revenue beat(12)4
Avg Revenue beat(12)0.02%
Revenue beat(16)6
Avg Revenue beat(16)0.83%
PT rev (1m)2.36%
PT rev (3m)-42.76%
EPS NQ rev (1m)3.45%
EPS NQ rev (3m)-12.5%
EPS NY rev (1m)3.43%
EPS NY rev (3m)-40.24%
Revenue NQ rev (1m)0.05%
Revenue NQ rev (3m)-1.97%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)-1.36%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.56
P/FCF 25.06
P/OCF 13.12
P/B 2.64
P/tB 13.05
EV/EBITDA N/A
EPS(TTM)-0.32
EYN/A
EPS(NY)-0.21
Fwd EYN/A
FCF(TTM)0.27
FCFY3.99%
OCF(TTM)0.51
OCFY7.62%
SpS4.27
BVpS2.52
TBVpS0.51
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -6.23%
ROE -16.74%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 53.3%
FCFM 6.22%
ROA(3y)-9.14%
ROA(5y)-9.1%
ROE(3y)-18.55%
ROE(5y)-17.56%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.78%
GM growth 5Y18.27%
F-Score6
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF 4.81
Debt/EBITDA N/A
Cap/Depr 97.26%
Cap/Sales 5.66%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.62
Quick Ratio 1.62
Altman-Z 1.08
F-Score6
WACC8.09%
ROIC/WACCN/A
Cap/Depr(3y)148.24%
Cap/Depr(5y)145.57%
Cap/Sales(3y)5.59%
Cap/Sales(5y)4.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70%
EPS Next Y16.89%
EPS Next 2Y25.41%
EPS Next 3Y25.49%
EPS Next 5Y37.83%
Revenue 1Y (TTM)23.4%
Revenue growth 3Y21.14%
Revenue growth 5Y42.93%
Sales Q2Q%16.48%
Revenue Next Year19.4%
Revenue Next 2Y15.74%
Revenue Next 3Y15.2%
Revenue Next 5Y14.21%
EBIT growth 1Y36.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year168.05%
EBIT Next 3Y51.19%
EBIT Next 5Y36.81%
FCF growth 1Y344.71%
FCF growth 3Y-24.1%
FCF growth 5YN/A
OCF growth 1Y899.69%
OCF growth 3Y-8.47%
OCF growth 5YN/A

ACV AUCTIONS INC-A / ACVA FAQ

What is the ChartMill fundamental rating of ACV AUCTIONS INC-A (ACVA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ACVA.


Can you provide the valuation status for ACV AUCTIONS INC-A?

ChartMill assigns a valuation rating of 2 / 10 to ACV AUCTIONS INC-A (ACVA). This can be considered as Overvalued.


What is the profitability of ACVA stock?

ACV AUCTIONS INC-A (ACVA) has a profitability rating of 2 / 10.


What is the expected EPS growth for ACV AUCTIONS INC-A (ACVA) stock?

The Earnings per Share (EPS) of ACV AUCTIONS INC-A (ACVA) is expected to grow by 16.89% in the next year.